Multiplex Assay Kit for Serpin B3 (SERPINB3) ,etc. by FLIA (Flow Luminescence Immunoassay)

SCCA1; T4-A; Serpin Peptidase Inhibitor,Clade B(ovalbumin),Member 3; Serpin B3

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Serpin B3 (SERPINB3) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Serpin B3 (SERPINB3) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Serpin B3 (SERPINB3) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Serpin B3 (SERPINB3) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 90-98 93
EDTA plasma(n=5) 89-96 92
heparin plasma(n=5) 92-101 96
sodium citrate plasma(n=5) 89-97 93

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Serpin B3 (SERPINB3) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Serpin B3 (SERPINB3) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Serpin B3 (SERPINB3) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 86-101% 94-105% 86-101% 83-91%
EDTA plasma(n=5) 84-95% 87-98% 84-96% 96-103%
heparin plasma(n=5) 79-102% 83-101% 85-98% 96-104%
sodium citrate plasma(n=5) 95-104% 78-90% 80-90% 93-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:SERPINB3) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLOS ONE Susceptibility to COPD: Differential Proteomic Profiling after Acute Smoking Pubmed:25036363
Annals of Clinical Biochemistry Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis. pubmed:28766361
Head & neck Combination of serum squamous cell carcinoma antigens 1 and 2 as potential diagnostic marker for sinonasal squamous cell carcinoma and inverted papilloma Pubmed: 30376194
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB372Hu02 Recombinant Serpin B3 (SERPINB3) Positive Control; Immunogen; SDS-PAGE; WB.
RPB372Hu01 Recombinant Serpin B3 (SERPINB3) Positive Control; Immunogen; SDS-PAGE; WB.
EPB372Hu61 Eukaryotic Serpin B3 (SERPINB3) Positive Control; Immunogen; SDS-PAGE; WB.
RPB372Hu03 Recombinant Serpin B3 (SERPINB3) Positive Control; Immunogen; SDS-PAGE; WB.
PAB372Hu03 Polyclonal Antibody to Serpin B3 (SERPINB3) WB; IHC; ICC; IP.
PAB372Hu01 Polyclonal Antibody to Serpin B3 (SERPINB3) WB; ICC; IHC-P; IHC-F; ELISA.
PAB372Hu02 Polyclonal Antibody to Serpin B3 (SERPINB3) WB; IHC; ICC; IP.
MAB372Hu24 Monoclonal Antibody to Serpin B3 (SERPINB3) WB; IHC.
MAB372Hu22 Monoclonal Antibody to Serpin B3 (SERPINB3) WB; IHC; ICC; IP.
MAB372Hu21 Monoclonal Antibody to Serpin B3 (SERPINB3) WB; IHC; ICC; IP.
MAB372Hu23 Monoclonal Antibody to Serpin B3 (SERPINB3) WB.
SEB372Hu ELISA Kit for Serpin B3 (SERPINB3) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB372Hu CLIA Kit for Serpin B3 (SERPINB3) Chemiluminescent immunoassay for Antigen Detection.
LMB372Hu Multiplex Assay Kit for Serpin B3 (SERPINB3) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.